Simple research view

HUM · Humana Inc.

$381.15 latest stored close

Detected setup High Tight Flag

Watch · Quality 22/100

Ask about HUM

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$HUM

Humana Inc.

Humana Inc. is a large-cap Managed Health Care company in the Health Services sector with a market cap of $46B.

Strong Buy · 80 Health Services Managed Health Care stock Stage 2 · Advancing Base 1 Data 57m ago

$381.15 latest close

← Back Join to Watchlist $HUM Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 6 watch · 0 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Wednesday, July 29, 2026 Time not confirmed No sourced report session or clock time

Ordinary position sizing suppressed. Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.

Deterministic evidence

HUM-2.10%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. -2.12 points vs SPY.

CatalystUnavailable Stock reactionNegative Sector reactionUnavailable Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $381.15 Jul 27 close

52W High $428.88 -11.1%

52W Low $163.11

Wks Since High 1w

Base Depth -12.2%

Base B1

SMA 50 $362.42

SMA 200 $263.54

Avg Vol 1,389,947

RS Rank 95

RS vs High -6.1%

RS Slope -1.7% ▼

Grp Rank #30/64

ADR% 3.6%

ATR(14) $14.40 (3.8%)

Rel Vol (today) 0.78×

Vol Pace N/A

U/D Vol 1.11

A/D Days 21A / 13D

A/D Rating A+

VDU Bars 0/10 d

Earnings tmrw

$163.11

$428.88 82%

HUM Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for HUM.

Create Free Account

Setup Quality B 4/7 signals

Score trend

✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 65.5 (B) ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$HUM · $381.15 · as of 2026-07-27 · multi-factor read

/ 100

Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$362.42 ↑

100-day$282.47 ↑

200-day$263.54 ↑

Bullish (50 > 200)

RSI (14)

Reading48.5 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening

Histogram-4.707

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-3% · 7.5%

Squeeze — volatility compressing

Piercing the lower band — capitulation or strong selling. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.11 · Neutral

Rel volume0.78×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $415.00swing level

R · $428.8852-week high

Price · $381.15now

S · $353.06swing level

S · $254.38swing level

S · $186.00swing level

Fibonacci · Uptrend swing

23.6%$366.16

38.2%$327.36

50.0%$296.00

61.8%$264.63

78.6%$219.98

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for HUM — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 92 (leader)

Want this read in a legend's voice? 💬 Ask a Legend about HUM

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 6 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Watch

Minervini B

Trend-template read: 9/12 pass; wait for the soft misses to improve.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $381.15, MA150 $264.22, MA200 $263.54

1.2 150-day MA > 200-day MAMA150 $264.22 vs MA200 $263.54

Failing evidence

2. Quarterly EPS growth ≥ 25%From SEPA scan

2. ROE ≥ 17%From SEPA scan

9/12 checks

Method → Playbook → Ask →

O'Neil

Watch

O'Neil D

CANSLIM read: 4/8 pass; improvement is still needed.

Passing evidence

C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B

L: RS rank ≥ 80 (IBD leadership)RS rank 92

Failing evidence

A: Annual earnings & revenue qualityRev +10.1%

S: Volume ≥ 40% above average on breakoutVolume ratio 0.78x

4/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $381.15 vs MA200 $263.54

Failing evidence

Volume expansion above averageVolume ratio 0.78x

6/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$381.15

Relative strengthRS 92

Failing evidence

Volume vs average0.78x

Pivotal point cleared on expanding volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$381.15

Relative strengthRS 92

Failing evidence

Volume vs average0.78x

Box top broken on heavy volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$381.15

Relative strengthRS 92

Failing evidence

Volume vs average0.78x

Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending

4/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +15 A+

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 3/7 met

C 3/7 SEPA

Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY +10%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✓ RS rating ≥80 (leadership) 92

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -11.1%

Method Playbook

📋 Trade it like Wyckoff EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

High Tight Flag

83.9 score

RS Score 92

Trend 8/8 ✓

CANSLIM 65.5* (B)

105.7% pole 3.3% pullback

Why This Setup?

High Tight Flag

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met

In a confirmed uptrend Stage 2 · Trend 8/8
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 0.8× average — light
Clear of earnings in 1 days — event risk
A relative-strength leader RS 95

Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $381.15 vs SMA150 $264.22 / SMA200 $263.54

SMA 150 above SMA 200 SMA150 $264.22 vs SMA200 $263.54

SMA 200 trending up Slope +12.97 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $362.42

Price above SMA 50 $381.15 vs SMA50 $362.42

30%+ above 52W low +133.7% from $163.11

Within 25% of 52W high -11.1% from $428.88

RS score above 70 RS 92

Fundamentals

52W Range

82%

Mkt Cap SEC

45.8B

Rev YoY

+10%

EPS TTM

$9.84

P/E TTM

38.7x

Float

120M

Insider

No Buy

Company

Legend AI snapshot

Humana Inc.

HUM · NYSE · Health Services · Managed Health Care

$381.15latest close $45.8Bmarket cap 95RS rank 84setup score

O'Neil · Grade Card

CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market

B 65.5* CANSLIM * disqualified on M

C · Curr. EPS

A · Annual EPS

N · New Highs

S · Supply/Demand

L · Leader RS

I · Inst. Spons.

100

M · Market

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

8/8

W. RS

100

W. Support

$163.11

W. Resist

$428.88

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Jul 28

High Tight Flag ✓ Gate

Jul 28

High Tight Flag ✓ Gate

Jul 27

High Tight Flag ✓ Gate

90 0.0%

Jul 27

High Tight Flag ✓ Gate

90 0.0%

Jul 27

High Tight Flag ✓ Gate

89 0.0%

Jul 27

High Tight Flag ✓ Gate

87 0.0%

Get the full picture on HUM

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial